Follow
Eddy Sotelo, ORCID: 0000-0001-5571-2812
Eddy Sotelo, ORCID: 0000-0001-5571-2812
Full Professor of Medicinal Chemistry, CIQUS, Santiago de Compostela University.
Verified email at usc.es - Homepage
Title
Cited by
Cited by
Year
3D printing of a heterogeneous copper-based catalyst
CR Tubío, J Azuaje, L Escalante, A Coelho, F Guitián, E Sotelo, A Gil
Journal of catalysis 334, 110-115, 2016
2242016
Pyridazines. Part XXIX: synthesis and platelet aggregation inhibition activity of 5-substituted-6-phenyl-3 (2H)-pyridazinones. Novel aspects of their biological actions
E Sotelo, N Fraiz, M Yáñez, V Terrades, R Laguna, E Cano, E Raviña
Bioorganic & medicinal chemistry 10 (9), 2873-2882, 2002
1072002
An efficient and recyclable 3D printed α-Al2O3 catalyst for the multicomponent assembly of bioactive heterocycles
J Azuaje, CR Tubío, L Escalante, M Gómez, F Guitián, A Coelho, ...
Applied Catalysis A: General 530, 203-210, 2017
1032017
Three-Dimensional Printing in Catalysis: Combining 3D Heterogeneous Copper and Palladium Catalysts for Multicatalytic Multicomponent Reactions
AS Diaz-Marta, CR Tubio, C Carbajales, C Fernandez, L Escalante, ...
ACS Catalysis  8 (1), 392-404, 2018
982018
Polymer‐Supported 1, 5, 7‐Triazabicyclo [4.4. 0] dec‐5‐ene as Polyvalent Ligands in the Copper‐Catalyzed Huisgen 1, 3‐Dipolar Cycloaddition
A Coelho, P Diz, O Caamano, E Sotelo
Advanced Synthesis & Catalysis 352 (7), 1179-1192, 2010
962010
Structural Modifications of N-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-Aryl-1-piperazinehexanamides: Influence on Lipophilicity and 5-HT7 Receptor Activity. Part III
M Leopoldo, E Lacivita, P De Giorgio, C Fracasso, S Guzzetti, S Caccia, ...
Journal of medicinal chemistry 51 (18), 5813-5822, 2008
902008
Structural mapping of adenosine receptor mutations: ligand binding and signaling mechanisms
W Jespers, AC Schiedel, LH Heitman, RM Cooke, L Kleene, ...
Trends in Pharmacological Sciences 39 (1), 75-89, 2018
832018
Pyridazines. Part 36: Synthesis and antiplatelet activity of 5-substituted-6-phenyl-3 (2H)-pyridazinones
A Coelho, E Sotelo, N Fraiz, M Yáñez, R Laguna, E Cano, E Raviña
Bioorganic & medicinal chemistry letters 14 (2), 321-324, 2004
822004
Pyridazine derivatives. Part 33: Sonogashira approaches in the synthesis of 5-substituted-6-phenyl-3 (2H)-pyridazinones
A Coelho, E Sotelo, E Raviña
Tetrahedron 59 (14), 2477-2484, 2003
802003
Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists
A Crespo, A El Maatougui, P Biagini, J Azuaje, A Coelho, J Brea, MI Loza, ...
ACS Medicinal Chemistry Letters 4 (11), 1031-1036, 2013
762013
Pyrimidine Derivatives as Potent and Selective A3 Adenosine Receptor Antagonists
V Yaziji, D Rodriguez, H Gutiérrez-de-Terán, A Coelho, O Caamano, ...
Journal of medicinal chemistry 54 (2), 457-471, 2011
742011
Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes
A El Maatougui, J Azuaje, M Gonzalez-Gomez, G Miguez, A Crespo, ...
Journal of medicinal chemistry 59 (5), 1967-1983, 2016
682016
Pyridazine derivatives. Part 21: synthesis and structural study of novel 4-aryl-2, 5-dioxo-8-phenylpyrido [2, 3-d] pyridazines
B Pita, E Sotelo, M Suárez, E Raviña, E Ochoa, Y Verdecia, H Novoa, ...
Tetrahedron 56 (16), 2473-2479, 2000
602000
Pyridazines. XV. Synthesis of 6‐aryl‐5‐amino‐3(2H)‐pyridazinones as potential platelet aggregation inhibitors
I Estevez, E Raviña, E Sotelo
Journal of heterocyclic chemistry 35 (6), 1421-1428, 1998
531998
1, 5-Dimethyl-6H-pyridazino [4, 5-b] carbazole, a 3-Aza Bioisoster of the Antitumor Alkaloid Olivacine
N Haider, E Sotelo
Chemical and pharmaceutical bulletin 50 (11), 1479-1483, 2002
522002
Molecular modelling of G protein‐coupled receptors through the web
D Rodríguez, X Bello, H Gutiérrez‐de‐Terán
Molecular Informatics 31 (5), 334-341, 2012
502012
Pyridazines. Part 28: 5-alkylidene-6-phenyl-3(2H)-pyridazinones, a new family of platelet aggregation inhibitors
E Sotelo, N Fraiz, M Yanez, R Laguna, E Cano, J Brea, E Raviña
Bioorganic & medicinal chemistry letters 12 (12), 1575-1577, 2002
482002
Design, Synthesis, and Structure−Activity Relationships of 1-,3-,8-, and 9-Substituted-9-deazaxanthines at the Human A2B Adenosine Receptor
A Carotti, MI Cadavid, NB Centeno, C Esteve, MI Loza, A Martinez, ...
Journal of medicinal chemistry 49 (1), 282-299, 2006
472006
Pyridazines. XIII. Synthesis of 6-Aryl-5-Oxygenated Substituted-3(2H)-Pyridazinones and Evaluation as Platelet Aggregation Inhibitors
R Laguna, B Rodriguez-Linares, E Cano, I ESTEVEZ, E RAVINA, ...
Chemical & pharmaceutical bulletin 45 (7), 1151-1155, 1997
471997
Pyridazine derivatives 32: stille-based approaches in the synthesis of 5-substituted-6-phenyl-3 (2H)-pyridazinones
E Sotelo, A Coelho, E Raviña
Chemical and pharmaceutical bulletin 51 (4), 427-430, 2003
432003
The system can't perform the operation now. Try again later.
Articles 1–20